Skip to main content

Table 1 Overall demographic and clinical characteristics of test-positive and test-negative subjects, and population controls (for the case–control design 2) by autoimmune status

From: Association between autoimmune diseases and COVID-19 as assessed in both a test-negative case–control and population case–control design

 

Test-positive subjects

Test-negative subjects

Controls (for case–control design 2)

Overall

Autoimmune status

Overall

Autoimmune status

Overall

Autoimmune status

No

Yes

No

Yes

No

Yes

n = 20,364

n = 19,699 96.7%

n = 665 3.3%

n = 34,697

n = 33,400 96.3%

n = 1297 3.7%

n = 81,414

n = 79,245 97.3%

n = 2169 2.7%

Gender = Male (%)

9666 (47.5)

9496 (48.2)

170 (25.6)

13,658 (39.4)

13,438 (40.2)

220 (17)

38,659 (47.5)

38,127 (48.1)

532 (24.5)

Age mean (sd)

65.5 (19.4)

65.6 (19.5)

64.5 (16.1)

54.8 (20.8)

54.8 (20.95)

56.9 (16.4)

65.5 (19.4)

65.5 (19.5)

66.2 (16.1)

Age class (years) (%)

 < 17

171 (0.8)

170 (0.9)

1 (0.2)

905 (2.6)

902 (2.7)

3 (0.2)

684 (0.8)

682 (0.9)

2 (0.1)

 [18–40)

1907 (9.4)

1868 (9.5)

39 (5.9)

7521 (21.7)

7353 (22)

168 (13)

7629 (9.4)

7512 (9.5)

117 (5.4)

 [40–70)

8622 (42.3)

8264 (42)

358 (53.8)

17,047 (49.1)

16,241 (48.6)

806 (62.1)

34,488 (42.4)

33,452 (42.2)

1036 (47.8)

 ≥ 70

9664 (47.5)

9397 (47.7)

267 (40.2)

9224 (26.6)

8904 (26.7)

320 (24.7)

38,613 (47.4)

37,599 (47.4)

1014 (46.7)

Geographic location (%)

 Lodi province (start of the outburst)

2939 (14.4)

2836 (14.4)

103 (15.5)

5185 (14.9)

5001 (15)

184 (14.2)

11,675 (14.3)

11,356 (14.3)

319 (14.7)

 City of Milan

7235 (35.5)

7025 (35.7)

210 (31.6)

13,188 (38)

12,761 (38.2)

427 (32.9)

29,185 (35.8)

28,437 (35.9)

748 (34.5)

 Milan province

10,190 (50)

9838 (49.9)

352 (52.9)

16,324 (47)

15,638 (46.8)

686 (52.9)

40,554 (49.8)

39,452 (49.8)

1102 (50.8)

Setting (%)

 Home

6122 (30.1)

5861 (29.8)

261 (39.2)

 Residential

3381 (16.6)

3319 (16.8)

62 (9.3)

 Residential followed by hospitalization

556 (2.7)

548 (2.8)

8 (1.2)

 Hospitalized

10,305 (50.6)

9971 (50.6)

334 (50.2)

Health status

 Non-hospitalized and alive

8292 (40.7)

7998 (40.6)

294 (44.2)

 Hospitalized and alive

7949 (39.0)

7692 (39.0)

257 (38.6)

 Deceased

4123 (20.2)

4009 (20.4)

114 (17.1)

Number of comorbidities (Excluded autoimmune diseases)

 None

8265 (40.6)

8105 (41.1)

160 (24.1)

18,870 (54.4)

18,457 (55.3)

413 (31.8)

36,658 (45)

36,131 (45.6)

527 (24.3)

 1–3

8951 (44)

8581 (43.6)

370 (55.6)

11,959 (34.5)

11,286 (33.8)

673 (51.9)

36,156 (44.4)

34,862 (44)

1294 (59.7)

 ≥ 4

3148 (15.5)

3013 (15.3)

135 (20.3)

3868 (11.1)

3657 (10.9)

211 (16.3)

8600 (10.6)

8252 (10.4)

348 (16)

 Comorbidities (%)

 Transplanted any time = Yes (%)

77 (0.4)

75 (0.4)

2 (0.3)

227 (0.7)

221 (0.7)

6 (0.5)

159 (0.2)

155 (0.2)

4 (0.2)

 Blood and Hematopoietic organs = Yes (%)

30 (0.1)

27 (0.1)

3 (0.5)

64 (0.2)

57 (0.2)

7 (0.5)

85 (0.1)

80 (0.1)

5 (0.2)

 HIV infection or AIDS = Yes (%)

72 (0.4)

72 (0.4)

0 (0)

224 (0.6)

220 (0.7)

4 (0.3)

261 (0.3)

259 (0.3)

2 (0.1)

 Tumor in first line treatment = Yes (%)

1024 (5)

923 (4.7)

101 (15.2)

2027 (5.8)

1869 (5.6)

158 (12.2)

3303 (4.1)

3023 (3.8)

280 (12.9)

 Tumor in follow-up, 1–5 years = Yes (%)

788 (3.9)

759 (3.9)

29 (4.4)

1128 (3.3)

1071 (3.2)

57 (4.4)

3153 (3.9)

3050 (3.8)

103 (4.7)

 Tumor in remission after 5 years = Yes (%)

1087 (5.3)

1038 (5.3)

49 (7.4)

1337 (3.9)

1269 (3.8)

68 (5.2)

4238 (5.2)

4088 (5.2)

150 (6.9)

 Type 1 diabetes = Yes (%)

28 (0.1)

28 (0.1)

0 (0)

79 (0.2)

76 (0.2)

3 (0.2)

58 (0.1)

54 (0.1)

4 (0.2)

 Type 2 diabetes = Yes (%)

2426 (11.9)

2357 (12)

69 (10.4)

2537 (7.3)

2434 (7.3)

103 (7.9)

7660 (9.4)

7433 (9.4)

227 (10.5)

 Complicated DM Type 1 and 2 = Yes (%)

423 (2.1)

408 (2.1)

15 (2.3)

527 (1.5)

503 (1.5)

24 (1.9)

750 (0.9)

722 (0.9)

28 (1.3)

 Hypercholesterolaemia = Yes (%)

2301 (11.3)

2216 (11.2)

85 (12.8)

2614 (7.5)

2495 (7.5)

119 (9.2)

9607 (11.8)

9306 (11.7)

301 (13.9)

 Arterial hypertension = Yes (%)

8187 (40.2)

7896 (40.1)

291 (43.8)

9454 (27.2)

9016 (27)

438 (33.8)

32,202 (39.6)

31,267 (39.5)

935 (43.1)

 Ischemic heart disease = Yes (%)

2364 (11.6)

2297 (11.7)

67 (10.1)

2744 (7.9)

2617 (7.8)

127 (9.8)

7497 (9.2)

7273 (9.2)

224 (10.3)

 Valvular heart disease = Yes (%)

475 (2.3)

458 (2.3)

17 (2.6)

678 (2)

647 (1.9)

31 (2.4)

1328 (1.6)

1287 (1.6)

41 (1.9)

 Cardiomyopathy with arrhythmia = Yes (%)

2310 (11.3)

2241 (11.4)

69 (10.4)

2614 (7.5)

2503 (7.5)

111 (8.6)

6850 (8.4)

6634 (8.4)

216 (10)

 Cardiomyopathy without arrhythmia = Yes (%)

1699 (8.3)

1641 (8.3)

58 (8.7)

2025 (5.8)

1941 (5.8)

84 (6.5)

5278 (6.5)

5129 (6.5)

149 (6.9)

 Chronic hearth failure = Yes (%)

1401 (6.9)

1346 (6.8)

55 (8.3)

1764 (5.1)

1680 (5)

84 (6.5)

3567 (4.4)

3463 (4.4)

104 (4.8)

 Peripheral artery disease = Yes (%)

595 (2.9)

573 (2.9)

22 (3.3)

820 (2.4)

784 (2.3)

36 (2.8)

1334 (1.6)

1290 (1.6)

44 (2)

 Venous diseases = Yes (%)

201 (1)

192 (1)

9 (1.4)

281 (0.8)

259 (0.8)

22 (1.7)

580 (0.7)

562 (0.7)

18 (0.8)

 Cerebrovascular disease = Yes (%)

822 (4)

799 (4.1)

23 (3.5)

932 (2.7)

884 (2.6)

48 (3.7)

1653 (2)

1607 (2)

46 (2.1)

 Thyroid diseases = Yes (%)

1137 (5.6)

783 (4)

354 (53.2)

2149 (6.2)

1357 (4.1)

792 (61.1)

4106 (5)

2872 (3.6)

1234 (56.9)

 Other endocrine diseases = Yes (%)

78 (0.4)

70 (0.4)

8 (1.2)

173 (0.5)

150 (0.4)

23 (1.8)

225 (0.3)

211 (0.3)

14 (0.6)

 Other autoimmune diseases = Yes (%)

359 (1.8)

22 (0.1)

337 (50.7)

601 (1.7)

47 (0.1)

554 (42.7)

1095 (1.3)

63 (0.1)

1032 (47.6)

 Epilepsy = Yes (%)

271 (1.3)

257 (1.3)

14 (2.1)

393 (1.1)

380 (1.1)

13 (1)

598 (0.7)

577 (0.7)

21 (1)

 Alzheimer and dementias = Yes (%)

669 (3.3)

655 (3.3)

14 (2.1)

579 (1.7)

562 (1.7)

17 (1.3)

989 (1.2)

968 (1.2)

21 (1)

 Parkinson and parkinsonisms = Yes (%)

310 (1.5)

305 (1.5)

5 (0.8)

287 (0.8)

279 (0.8)

8 (0.6)

616 (0.8)

596 (0.8)

20 (0.9)

 Nervous system diseases, others = Yes (%)

99 (0.5)

94 (0.5)

5 (0.8)

232 (0.7)

218 (0.7)

14 (1.1)

263 (0.3)

257 (0.3)

6 (0.3)

 Chronic hepatitis and cirrhosis = Yes (%)

433 (2.1)

413 (2.1)

20 (3)

705 (2)

666 (2)

39 (3)

1293 (1.6)

1248 (1.6)

45 (2.1)

 Digestive system diseases, others = Yes (%)

254 (1.2)

243 (1.2)

11 (1.7)

459 (1.3)

434 (1.3)

25 (1.9)

763 (0.9)

710 (0.9)

53 (2.4)

 COPD = Yes (%)

897 (4.4)

864 (4.4)

33 (5)

1089 (3.1)

1039 (3.1)

50 (3.9)

2433 (3)

2345 (3)

88 (4.1)

 RF or oxygen therapy = Yes (%)

97 (0.5)

91 (0.5)

6 (0.9)

151 (0.4)

142 (0.4)

9 (0.7)

221 (0.3)

207 (0.3)

14 (0.6)

 Asthma = Yes (%)

443 (2.2)

422 (2.1)

21 (3.2)

833 (2.4)

776 (2.3)

57 (4.4)

1369 (1.7)

1303 (1.6)

66 (3)

 CKD = Yes (%)

590 (2.9)

557 (2.8)

33 (5)

716 (2.1)

681 (2)

35 (2.7)

1464 (1.8)

1409 (1.8)

55 (2.5)

 Dialysis dependent CKD = Yes (%)

151 (0.7)

147 (0.7)

4 (0.6)

443 (1.3)

427 (1.3)

16 (1.2)

122 (0.1)

121 (0.2)

1 (0)

Autoimmune diseases

 Acquired autoimmune hemolytic anemia

10 (1.5)

11 (0.8)

19 (0.9)

 Systemic sclerosis

21 (3.2)

47 (3.6)

51 (2.4)

 Ankylosing spondylitis

13 (2)

22 (1.7)

42 (1.9)

 Myasthenia gravis

20 (3)

21 (1.6)

39 (1.8)

 Rheumatoid arthritis

167 (25.1)

223 (17.2)

479 (22.1)

 Psoriatic arthritis

69 (10.4)

139 (10.7)

284 (13.1)

 Systemic lupus erythematosus

16 (2.4)

38 (2.9)

57 (2.6)

 Sjögren disease

26 (3.9)

60 (4.6)

70 (3.2)

 Hashimoto’s disease

323 (48.6)

736 (56.7)

1128 (52.0)